John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback